Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$692M |
| 2 |
Qiagen
QGEN
|
+$623M |
| 3 |
Autodesk
ADSK
|
+$477M |
| 4 |
Lam Research
LRCX
|
+$381M |
| 5 |
Match Group
MTCH
|
+$358M |
Top Sells
| 1 |
TSMC
TSM
|
+$545M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$421M |
| 3 |
Illumina
ILMN
|
+$408M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$400M |
| 5 |
Fidelity National Information Services
FIS
|
+$389M |
Sector Composition
| 1 | Technology | 22.25% |
| 2 | Financials | 17.64% |
| 3 | Healthcare | 15.25% |
| 4 | Industrials | 13.09% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
SelectQuote
SLQT
$351M
| $17.5M | 0.01% |
845,718
-64,532
| -7% | -$1.34M |
|
602
Outset Medical
OM
$245M
| $17.4M | 0.01% |
20,419
+3,821
| +23% | +$3.26M |
|
|
MILE
603
DELISTED
Metromile, Inc. Common Stock
MILE
| $17.3M | 0.01% |
+1,114,888
| New | +$17.3M |
|
|
AFIB
604
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $17.3M | 0.01% |
599,536
+128,740
| +27% | +$3.71M |
|
605
Altria Group
MO
$111B
| $17.2M | 0.01% |
419,293
-291,498
| -41% | -$12M |
|
606
Forward Air
FWRD
$913M
| $17.1M | 0.01% |
223,064
+16,940
| +8% | +$1.3M |
|
607
Biogen
BIIB
$21.1B
| $17.1M | 0.01% |
69,752
-52,098
| -43% | -$12.8M |
|
608
BioAtla
BCAB
$41.9M
| $17M | 0.01% |
+499,871
| New | +$17M |
|
609
Waste Management
WM
$88.3B
| $17M | 0.01% |
143,903
-9,492
| -6% | -$1.12M |
|
610
American Water Works
AWK
$27.3B
| $16.9M | 0.01% |
110,205
-1,685
| -2% | -$259K |
|
|
SYNH
611
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $16.8M | 0.01% |
246,973
+186,968
| +312% | +$12.7M |
|
612
HP
HPQ
$27.1B
| $16.7M | 0.01% |
678,376
+620,534
| +1,073% | +$15.3M |
|
613
McDonald's
MCD
$223B
| $16.3M | 0.01% |
76,135
-7,473
| -9% | -$1.6M |
|
614
Twist Bioscience
TWST
$1.51B
| $16.1M | 0.01% |
114,023
-255,019
| -69% | -$36M |
|
615
Airbnb
ABNB
$75.8B
| $15.5M | 0.01% |
+105,679
| New | +$15.5M |
|
616
Construction Partners
ROAD
$6.78B
| $15.4M | ﹤0.01% |
528,643
-707,561
| -57% | -$20.6M |
|
617
Neurocrine Biosciences
NBIX
$14.3B
| $14.1M | ﹤0.01% |
147,120
+33,785
| +30% | +$3.24M |
|
618
Huntington Ingalls Industries
HII
$10.6B
| $13.9M | ﹤0.01% |
81,793
-115,242
| -58% | -$19.6M |
|
619
Globant
GLOB
$2.64B
| $13.9M | ﹤0.01% |
64,034
-7,630
| -11% | -$1.66M |
|
620
Cummins
CMI
$54.8B
| $13.7M | ﹤0.01% |
60,133
-1,059
| -2% | -$241K |
|
621
BioXcel Therapeutics
BTAI
$52.1M
| $13.7M | ﹤0.01% |
18,473
+341
| +2% | +$252K |
|
|
CELL
622
DELISTED
PhenomeX Inc. Common Stock
CELL
| $13.4M | ﹤0.01% |
150,065
+2,805
| +2% | +$251K |
|
623
Allegro MicroSystems
ALGM
$5.72B
| $13.3M | ﹤0.01% |
+500,000
| New | +$13.3M |
|
624
Incyte
INCY
$16.9B
| $13.3M | ﹤0.01% |
153,256
-8,325
| -5% | -$724K |
|
625
Collegium Pharmaceutical
COLL
$1.19B
| $13.2M | ﹤0.01% |
659,739
+9,940
| +2% | +$199K |
|